ITRM20020253A1 - Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. - Google Patents
Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche.Info
- Publication number
- ITRM20020253A1 ITRM20020253A1 IT2002RM000253A ITRM20020253A ITRM20020253A1 IT RM20020253 A1 ITRM20020253 A1 IT RM20020253A1 IT 2002RM000253 A IT2002RM000253 A IT 2002RM000253A IT RM20020253 A ITRM20020253 A IT RM20020253A IT RM20020253 A1 ITRM20020253 A1 IT RM20020253A1
- Authority
- IT
- Italy
- Prior art keywords
- gene
- snrna
- dystrophine
- therapeutic applications
- antisense sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000253A ITRM20020253A1 (it) | 2002-05-08 | 2002-05-08 | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. |
EP03749984A EP1501931B1 (en) | 2002-05-08 | 2003-05-06 | Chimeric snrna molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications |
PT03749984T PT1501931E (pt) | 2002-05-08 | 2003-05-06 | Moléculas de arnnp (snrna) quiméricas portadoras de sequências anti-sentido contra as junções de splicing do gene da distrofina e suas aplicações terapêuticas |
AT03749984T ATE449170T1 (de) | 2002-05-08 | 2003-05-06 | CHIMÄRE SNRNA MOLEKÜLE MIT ANTISENSE-SEQUENZEN GEGEN DIE ßSPLICE JUNCTIONSß DES DYSTROPHIN-GENS UND IHRE THERAPEUTISCHEN VERWENDUNGEN |
DK03749984.5T DK1501931T3 (da) | 2002-05-08 | 2003-05-06 | Kimære snRNA-molekyler, som bærer antisense-sekvenser mod splejsningsforbindelserne af dystrophingenet, og deres terapeutiske anvendelser |
EP09176221.1A EP2151497B1 (en) | 2002-05-08 | 2003-05-06 | Chimeric U1 and U2 snRNA molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications |
SI200331749T SI1501931T1 (sl) | 2002-05-08 | 2003-05-06 | Himerne molekule snrna ki nosijo protismiselne sekvence proti mestu cepitve distrofinskega gena innjihove terapevtske aplikacije |
DE60330136T DE60330136D1 (de) | 2002-05-08 | 2003-05-06 | Chimäre snrna moleküle mit antisense-sequenzen gegen die "splice junctions" des dystrophin-gens und ihre therapeutischen verwendungen |
ES03749984T ES2336909T3 (es) | 2002-05-08 | 2003-05-06 | Molaculas de arnsn quimericas que transportan secuencias antisentido contra las uniones por corte y empalme del gen de la distrofina y sus aplicaciones terapeuticas. |
PCT/IT2003/000273 WO2003095647A2 (en) | 2002-05-08 | 2003-05-06 | CHIMERIC snRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS |
AU2003231928A AU2003231928A1 (en) | 2002-05-08 | 2003-05-06 | CHIMERIC snRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS |
CY20101100102T CY1109746T1 (el) | 2002-05-08 | 2010-02-03 | Χιμαιρικα μορια snrna που φερουν αντιπληροφοριακες αλληλουχιες εναντι των συνδεσμων συρραφης του γονιδιου δυστροφινης και θεραπευτικες εφαρμογες αυτων |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000253A ITRM20020253A1 (it) | 2002-05-08 | 2002-05-08 | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20020253A0 ITRM20020253A0 (it) | 2002-05-08 |
ITRM20020253A1 true ITRM20020253A1 (it) | 2003-11-10 |
Family
ID=11456291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002RM000253A ITRM20020253A1 (it) | 2002-05-08 | 2002-05-08 | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1501931B1 (it) |
AT (1) | ATE449170T1 (it) |
AU (1) | AU2003231928A1 (it) |
CY (1) | CY1109746T1 (it) |
DE (1) | DE60330136D1 (it) |
DK (1) | DK1501931T3 (it) |
ES (1) | ES2336909T3 (it) |
IT (1) | ITRM20020253A1 (it) |
PT (1) | PT1501931E (it) |
SI (1) | SI1501931T1 (it) |
WO (1) | WO2003095647A2 (it) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
CN1796556A (zh) | 1998-03-20 | 2006-07-05 | 联邦科学和工业研究组织 | 控制基因表达 |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
AUPR621501A0 (en) | 2001-07-06 | 2001-08-02 | Commonwealth Scientific And Industrial Research Organisation | Delivery of ds rna |
CA2568603A1 (en) * | 2003-09-12 | 2005-03-24 | Commonwealth Scientific And Industrial Research Organisation | Modified gene-silencing nucleic acid molecules and uses thereof |
FR2874384B1 (fr) | 2004-08-17 | 2010-07-30 | Genethon | Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables |
WO2007123391A1 (en) | 2006-04-20 | 2007-11-01 | Academisch Ziekenhuis Leiden | Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene. |
EP1857548A1 (en) | 2006-05-19 | 2007-11-21 | Academisch Ziekenhuis Leiden | Means and method for inducing exon-skipping |
WO2008018795A1 (en) | 2006-08-11 | 2008-02-14 | Prosensa Technologies B.V. | Methods and means for treating dna repeat instability associated genetic disorders |
EP2152873A2 (en) * | 2007-03-16 | 2010-02-17 | Biorigen S.r.l | Gene expression regulation technology and noncoding rnas for diagnosis and therapy |
US8907075B2 (en) | 2007-03-30 | 2014-12-09 | Samuel Ian Gunderson | Compositions and methods for gene silencing |
WO2008121963A2 (en) * | 2007-03-30 | 2008-10-09 | Rutgers, The State University Of New Jersey | Compositions and methods for gene silencing |
US8343941B2 (en) | 2007-03-30 | 2013-01-01 | Rutgers, The State University Of New Jersey | Compositions and methods for gene silencing |
US9441221B2 (en) | 2007-03-30 | 2016-09-13 | Rutgers, The State University Of New Jersey | Compositions and methods for gene silencing |
DK2167136T3 (en) | 2007-07-12 | 2016-07-25 | Biomarin Tech Bv | Molecules for targeting compounds at different selected organs or tissues |
EP2167135A2 (en) | 2007-07-12 | 2010-03-31 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs, tissues or tumor cells |
NZ584793A (en) | 2007-10-26 | 2012-05-25 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
NZ587178A (en) | 2008-02-08 | 2011-11-25 | Prosensa Holding Bv | Methods and means for treating dna repeat instability associated genetic disorders |
EP2119783A1 (en) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means |
US8889641B2 (en) | 2009-02-11 | 2014-11-18 | The University Of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
JP2012524540A (ja) | 2009-04-24 | 2012-10-18 | プロセンサ テクノロジーズ ビー.ブイ. | Dmdを処置するためのイノシンを含むオリゴヌクレオチド |
EP2258863A1 (en) * | 2009-05-25 | 2010-12-08 | Universita'Degli Studi di Roma "La Sapienza" | miRNA biomarkers for the diagnosis of duchenne muscular dystrophy progression, for monitoring therapeutic interventions, and as therapeutics |
AU2010335039B2 (en) | 2009-12-24 | 2015-03-26 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Molecule for treating an inflammatory disorder |
EP2524037B1 (en) | 2010-01-12 | 2018-05-16 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
US9409953B2 (en) | 2011-02-10 | 2016-08-09 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
US9303258B2 (en) | 2011-04-05 | 2016-04-05 | The Regents Of The University Of California | Method and compositions comprising small RNA agonist and antagonists to modulate inflammation |
EP2806900B1 (en) | 2012-01-27 | 2021-12-15 | BioMarin Technologies B.V. | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
CA2885544A1 (en) | 2012-09-28 | 2014-04-03 | The University Of North Carolina At Chapel Hill | Aav vectors targeted to oligodendrocytes |
AU2014227766B2 (en) | 2013-03-15 | 2018-10-04 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding AAV vectors |
EP3517612A1 (en) | 2013-03-15 | 2019-07-31 | The University of North Carolina At Chapel Hill | Synthetic adeno-associated virus inverted terminal repeats |
EP4344741A2 (en) | 2014-11-21 | 2024-04-03 | The University of North Carolina at Chapel Hill | Aav vectors targeted to the central nervous system |
CA2972807C (en) | 2015-01-14 | 2024-01-16 | The University Of North Carolina At Chapel Hill | Methods and compositions for targeted gene transfer |
US10596247B2 (en) | 2015-02-20 | 2020-03-24 | Board Of Regents, The University Of Texas System | Methods and compositions for attenuated chlamydia as vaccine and vector |
IL292830B2 (en) | 2015-09-28 | 2023-06-01 | Univ Florida | Methods and compositions for stealth virus antibody vectors |
AU2018234695A1 (en) | 2017-03-15 | 2019-09-12 | The University Of North Carolina At Chapel Hill | Polyploid adeno-associated virus vectors and methods of making and using the same |
AU2019247746A1 (en) | 2018-04-03 | 2020-10-15 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
CN112533644A (zh) | 2018-04-03 | 2021-03-19 | 斯特里迪比奥公司 | 靶向眼组织的病毒载体 |
CA3094311A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
CA3104113A1 (en) | 2018-06-22 | 2019-12-26 | Asklepios Biopharmaceutical, Inc. | Vectors for gene delivery that persist within cells |
CN113727992A (zh) | 2019-03-21 | 2021-11-30 | 斯特里迪比奥公司 | 重组腺相关病毒载体 |
CA3137106A1 (en) | 2019-04-26 | 2020-10-29 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding aav2.5 vector |
CA3157700A1 (en) | 2019-10-17 | 2021-04-22 | Stridebio, Inc. | Adeno-associated viral vectors for treatment of niemann-pick disease type c |
WO2022093769A1 (en) | 2020-10-28 | 2022-05-05 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding aav2.5 vector |
CN116490514A (zh) | 2020-10-28 | 2023-07-25 | 北卡罗来纳-查佩尔山大学 | 用于双重聚糖结合aav2.5载体的方法和组合物 |
TW202242124A (zh) | 2021-01-14 | 2022-11-01 | 美商史崔德生物公司 | 靶向t細胞之aav載體 |
JP2024503725A (ja) | 2021-01-15 | 2024-01-26 | アウトペース バイオ インコーポレイテッド | 小分子調節遺伝子発現システム |
US20240189447A1 (en) | 2021-04-16 | 2024-06-13 | Asklepios Biopharmaceutical, Inc. | Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response |
WO2023150687A1 (en) | 2022-02-04 | 2023-08-10 | Ginkgo Bioworks, Inc. | Recombinant adeno-associated virus vectors, and methods of use thereof |
US20230348909A1 (en) * | 2022-03-30 | 2023-11-02 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
CN115806984B (zh) * | 2022-10-18 | 2023-10-10 | 昆明理工大学 | 环状rna及载体和载体的应用 |
WO2024124019A2 (en) | 2022-12-07 | 2024-06-13 | Ginkgo Bioworks, Inc. | Aav vectors targeting hematopoietic stem cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1191097A1 (en) * | 2000-09-21 | 2002-03-27 | Leids Universitair Medisch Centrum | Induction of exon skipping in eukaryotic cells |
-
2002
- 2002-05-08 IT IT2002RM000253A patent/ITRM20020253A1/it unknown
-
2003
- 2003-05-06 DE DE60330136T patent/DE60330136D1/de not_active Expired - Lifetime
- 2003-05-06 DK DK03749984.5T patent/DK1501931T3/da active
- 2003-05-06 SI SI200331749T patent/SI1501931T1/sl unknown
- 2003-05-06 ES ES03749984T patent/ES2336909T3/es not_active Expired - Lifetime
- 2003-05-06 AT AT03749984T patent/ATE449170T1/de active
- 2003-05-06 WO PCT/IT2003/000273 patent/WO2003095647A2/en not_active Application Discontinuation
- 2003-05-06 EP EP03749984A patent/EP1501931B1/en not_active Expired - Lifetime
- 2003-05-06 EP EP09176221.1A patent/EP2151497B1/en not_active Expired - Lifetime
- 2003-05-06 PT PT03749984T patent/PT1501931E/pt unknown
- 2003-05-06 AU AU2003231928A patent/AU2003231928A1/en not_active Abandoned
-
2010
- 2010-02-03 CY CY20101100102T patent/CY1109746T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003095647A2 (en) | 2003-11-20 |
ES2336909T3 (es) | 2010-04-19 |
CY1109746T1 (el) | 2014-09-10 |
AU2003231928A1 (en) | 2003-11-11 |
EP1501931A2 (en) | 2005-02-02 |
WO2003095647A3 (en) | 2004-02-19 |
SI1501931T1 (sl) | 2010-03-31 |
ATE449170T1 (de) | 2009-12-15 |
AU2003231928A8 (en) | 2003-11-11 |
DE60330136D1 (de) | 2009-12-31 |
EP2151497A2 (en) | 2010-02-10 |
ITRM20020253A0 (it) | 2002-05-08 |
PT1501931E (pt) | 2010-02-23 |
EP1501931B1 (en) | 2009-11-18 |
EP2151497B1 (en) | 2014-01-08 |
DK1501931T3 (da) | 2010-03-29 |
EP2151497A3 (en) | 2010-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITRM20020253A1 (it) | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. | |
ITRM20030149A1 (it) | Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico | |
CY1117852T1 (el) | Επαγωγη παρακαμψης εξωνιου σε ευκαριωτικα κυτταρα | |
ATE432291T1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
HUP0301246A2 (hu) | Humán véralvadási faktor VII változatai | |
MXPA02012743A (es) | Moleculas tipo il-17 y usos de las mismas. | |
DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
NO20052956L (no) | Defensinprotiner | |
DK2219031T3 (da) | Anvendelse af leptin til behandling af human lipoatrofi og fremgangsmåde til bestemmelse af prædisposition for behandlinngen | |
EA200400812A1 (ru) | Секретируемый белок | |
EA200001124A1 (ru) | Способ генной терапии | |
FI961202A (fi) | Grb3-3-geeni, sen variantteja ja niiden käyttöjä | |
BR9902019A (pt) | Moléculas de polinucleotìdios que codificam proteìnas de neospora. | |
ITRM980367A0 (it) | Sequenza nucleotidiche del gene lrpkm1 di melo, sequenze amminoacidiche e loro usi | |
ES2172801T3 (es) | Procedimiento y dispositivo para la purificacion y enriquecimiento de moleculas. | |
PL374550A1 (en) | Il-17 like molecules and uses thereof | |
ATE556140T1 (de) | Aav vektoren für die gentherapie von rheumatischer arthritis | |
ATE526400T1 (de) | Metalloproteaseproteine | |
BR0003561A (pt) | Processo para a preparação fermentativa de produtos metabólicos e para as sequências de nucleotìdeos codificando para o gene sod | |
CY1114199T1 (el) | Αντιπληροφοριακη διαμορφωση της εκφρασης της απολιποπρωτεϊνης β | |
Murphy et al. | Corrigendum to “Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver” | |
GB0312210D0 (en) | Amino acid sequences involved in endocytosis, nucleic acid sequences encoding such amino acid sequences, and use thereof in the field of cholesterol | |
EA200501843A1 (ru) | Tnf-подобный секретируемый белок | |
AU2003215179A8 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof | |
MD2188F1 (en) | Method of epilepsy treatment |